TP53 mutation is rare in primary myelofibrosis

Leukemia and Lymphoma

Volumn 54, Issue 7, 2013, Pages 1552-

  Greaves, Wesley O ^a   Verma, Shalini ^a   Bisrat, Tigist ^a   Strati, Paolo ^a   Rahimi, Hamed ^a   Paladugu, Abhaya V ^a   Luthra, Rajyalakshmi ^a   Patel, Keyur P ^a   Medeiros, L Jeffrey ^a   Yao, Hui ^a   Pierce, Sherry ^a   Bueso Ramos, Carlos E ^a   Verstovsek, Srdan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDMX; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADULT; AGED; BONE MARROW; CANCER GENETICS; CANCER PROGNOSIS; CHROMOSOME 1Q; CLINICAL ARTICLE; CYTOGENETICS; EXON; FEMALE; GENE MUTATION; GENETIC SCREENING; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN TISSUE; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LETTER; MALE; MUTATION RATE; MYELOID METAPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

GENES, P53; HUMANS; MUTATION; PRIMARY MYELOFIBROSIS; PROGNOSIS;

EID: 84879401721     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.745527     Document Type: Letter

References (5)

1. Raza S, Viswanatha D, Frederick L, et al. TP53 mutations and polymorphisms in primary myelofibrosis. Am J Hematol 2012;87 : 204-206.
2. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000 ; 342:1255-1265.
3. Cervantes F, Barosi G. Myelofibrosis with myeloid metaplasia: diagnosis, prognostic factors, and staging. Semin Oncol 2005; 32: 395-402. (Pubitemid 41073752)
4. Barosi G, Hoff man R. I diopathic myelofibrosis. Semin Hematol 2005;42:248-258. (Pubitemid 41400666)
5. Harutyunyan A, KlampflT, C azzola M, et al. p 53 lesions in leukemic transformation. N Engl J Med 2011; 364: 488-490.